(Q46871180)

26 December 2017

title

Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells (English)

1 reference

26 December 2017

author

Yoshiro Saito

16

1 reference

26 December 2017

author name string

Kazuhide Ishikura

1

1 reference

26 December 2017

Hirofumi Misu

2

1 reference

26 December 2017

Masafumi Kumazaki

3

1 reference

26 December 2017

Hiroaki Takayama

4

1 reference

26 December 2017

Naoto Matsuzawa-Nagata

5

1 reference

26 December 2017

Natsumi Tajima

6

1 reference

26 December 2017

Keita Chikamoto

7

1 reference

26 December 2017

Fei Lan

8

1 reference

26 December 2017

Hitoshi Ando

9

1 reference

26 December 2017

Tsuguhito Ota

10

1 reference

26 December 2017

Masaru Sakurai

11

1 reference

26 December 2017

Yumie Takeshita

12

1 reference

26 December 2017

Kenichiro Kato

13

1 reference

26 December 2017

Akio Fujimura

14

1 reference

26 December 2017

Ken-Ichi Miyamoto

15

1 reference

26 December 2017

Satomi Kameo

17

1 reference

26 December 2017

Yasuo Okamoto

18

1 reference

26 December 2017

Yoh Takuwa

19

1 reference

26 December 2017

Kazuhiko Takahashi

20

1 reference

26 December 2017

Hiroyasu Kidoya

21

1 reference

26 December 2017

Nobuyuki Takakura

22

1 reference

26 December 2017

Shuichi Kaneko

23

1 reference

26 December 2017

Toshinari Takamura

24

1 reference

26 December 2017

publication date

3 July 2014

1 reference

26 December 2017

published in

Diabetologia

1 reference

26 December 2017

volume

57

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1968-1976

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-014-3306-9

exact match

0 references

cites work

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Peripheral arterial disease in diabetes--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Characterization of selenoprotein P as a selenium supply protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

A liver-derived secretory protein, selenoprotein P, causes insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Binding of selenoprotein P to heparin: characterization with surface plasmon resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Selenoprotein P associates with endothelial cells in rat tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Deletion of selenoprotein P alters distribution of selenium in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

VEGF signaling through NADPH oxidase-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Redox signaling in vascular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Diabetic retinopathy and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Abnormal angiogenesis in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Dual-specificity phosphatases: critical regulators with diverse cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Chemical forms of selenium in selenium containing proteins from human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3306-9

Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?

21 January 2018

1 reference

12 December 2020

Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease

1 reference

12 December 2020

Effect of diabetes mellitus on formation of coronary collateral vessels

1 reference

12 December 2020

Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes

1 reference

12 December 2020

Fluorometric Determination of Selenium in Biological Material with 2,3-Diaminonaphthalene

1 reference

12 December 2020

Low contribution of rice and vegetables to the daily intake of selenium in Japan

1 reference

12 December 2020

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

12 December 2020

Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis

1 reference

12 December 2020

Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals

1 reference

12 December 2020

10.1007/S00125-014-3306-9

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017